Strategies for Secondary AML and Emerging Therapies for AML

Decera Clinical Education Oncology Podcast · Jan 10, 2022 · 15m

In this podcast episode, Sarah M. Tinsley, PhD, APRN, AOCN, discusses management strategies for secondary AML and novel therapies currently in clinical trials for AML. Topics include:

Liposomal cytarabine plus daunorubicin for secondary AML

An overview of emerging immune-based strategies for AML

Evidence on immune-based therapies, including agents targeting CD47, TIM3, and bispecific antibodies

Presenter:

Sarah M. Tinsley, PhD, APRN, AOCN

Nurse Practitioner

Courtesy Assistant Professor

Department of Malignant Hematology

Moffitt Cancer Center

University of South Florida

Tampa, Florida

Hosted…